OMIX

Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stages I-IV colorectal cancer (CRC).

OMIX002406

1Summary
Title Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stages I-IV colorectal cancer (CRC).
Description This initial study reported the clinical performance of the patient-specific brPROPHETTM assay in CRC, demonstrating superior sensitivity in detecting preoperative and postoperative ctDNA than the fixed panel assays.
Organism Homo sapiens
Data Type Other Type of Genomic Data
Data Accessibility Controlled-access
BioProject PRJCA013318
Release Date 2022-11-22
Submitter Di Cao (caodi1@sysucc.org.cn)
Organization Sun Yat-sen University Cancer Center (SYSUCC)
Submission Date 2022-11-21
2Files & Download

The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX002406-01 figures 9 Other Type of Genomic Data 238.4 KB rar 0 Unavailable

Request for this Data View All Released Data of OMIX